Balanced news tone
News Sentiment
EWL sentiment intelligence
Edwards Lifesciences Corporation news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
87/100 classification confidence.
directly relevant articles
high-authority source matches
-3.6% over one week, +8.9% over four weeks, trend active, and near fair-value range.
Edwards Lifesciences shares may move 5% on July 23 earnings By Investing.com
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Edwards Lifesciences shares may move 5% on July 23 earnings By Investing.com
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Jul 2026 14:15
- Source
- Investing.com Nigeria
Insider Sell: Daniel Lippis Sells Shares of Edwards Lifesciences Corp (EW)
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 11 Jul 2026 00:46
- Source
- GuruFocus
Edwards Lifesciences (NYSE: EW) CVP exercises stock options and sells 619 shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 21:04
- Source
- Stock Titan
Edwards Lifesciences (EW) executive has shares withheld for tax on vesting
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 22:56
- Source
- Stock Titan
Edwards Lifesciences (NYSE: EW) exec sells 619 shares under 10b5-1 plan
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 07:00
- Source
- Stock Titan
Edwards Lifesciences presents fresh trial data, shares supported by robust S&P 500 positioning
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Jun 2026 07:00
- Source
- ad-hoc-news.de
Edwards Lifesciences stock hits 52-week high at 89.7 USD By Investing.com
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jun 2026 07:00
- Source
- Investing.com Canada
Edwards Lifesciences (NYSE: EW) files Form 144 for proposed common sale
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 May 2026 07:00
- Source
- Stock Titan
FTC moves to block Edwards Lifesciences’ acquisition of JenaValve
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 20 Aug 2025 07:00
- Source
- Medical Economics
Edwards Lifesciences prevails in heart valve dispute at the UPC
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jul 2025 07:00
- Source
- JUVE Patent
Edwards Lifesciences reports $14.6M in pay for CEO's first full year; median employee pay jumps
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Apr 2025 07:00
- Source
- Medical Design & Outsourcing
Epic battle over heart valves continues as EPO revokes two Edwards patents
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Apr 2025 07:00
- Source
- JUVE Patent
First main infringement hearing in Edwards vs Meril at Munich local division
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Sep 2024 07:00
- Source
- JUVE Patent
Edwards Lifesciences (EW) Stock Forecast and Price Target 2026 $EW
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 11 May 2024 14:34
- Source
- MarketBeat
What's Driving Edwards Lifesciences Corp's Surprising 19% Stock Rally?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 31 Jan 2024 08:00
- Source
- GuruFocus
EPO Boards of Appeal revoke Edwards Lifesciences’ heart-valve patent
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Dec 2023 08:00
- Source
- JUVE Patent
Edwards triggers $750M share repurchase program
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 01 Nov 2022 07:00
- Source
- MassDevice